Forensic · TLSIW
TriSalus Life Sciences
Top signals
Officer Departure Recent
C-suite officer departure (Item 5.02) in the last 6 months.
+4
Bear case preview · free
TriSalus Life Sciences' recent C-suite officer departure represents a potential governance instability signal, particularly concerning given the company's early-stage biotech profile where leadership continuity is material to execution and investor confidence. The departure warrants scrutiny into whether it reflects broader operational challenges, strategic disagreements, or simply routine transitions—a distinction that will materially affect risk assessment. Monitor the next 30-90 days for additional leadership changes, guidance revisions, or clinical program updates that might contextualize whether this departure is isolated or symptomatic of deeper issues.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
1 8-K event (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on TLSIW
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on TLSIW + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.